KINSHASA, Democratic Republic of the Congo / RankWire.AI / – The Democratic Republic of the Congo’s health authorities have launched a targeted Ebola vaccination effort in Kisangani, the capital of Tshopo Province, aiming to contain the country’s most severe outbreak ever recorded. Frontline healthcare workers, emergency response teams, and individuals with direct contact with confirmed cases are prioritized in the initial phase of vaccination deployment. Health Minister Roger Kamba confirmed that the campaign uses doses of the Ervebo vaccine to protect frontline personnel across the affected eastern provinces.
Official epidemiological reports reveal that the outbreak has spread through six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Data published by the Ministry of Public Health and Prevention indicate that there have been 5,713 confirmed cases and 2,744 deaths in the country. The case fatality rate among confirmed patients currently stands at around 48%.
International health organizations, including the World Health Organization, have stepped in to assist local health teams with logistics, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use protocol while observational data on its effectiveness against the circulating regional strain is collected by researchers. DR Congo’s vaccination initiative is complemented by ring-vaccination strategies targeting clusters of infections to break the chain of transmission.
DR Congo’s Eastern Provinces See Rollout of Ebola Vaccination Campaigns
Operational challenges are hampered by regional infrastructure issues, ongoing security risks, and high population mobility across border areas. In Kisangani, cold-chain logistics have been established to ensure the vaccines are stored at ultra-low temperatures before being transported to more remote health zones. DR Congo initiates Ebola vaccination efforts, with civil defense and community health workers conducting outreach to improve disease surveillance and reporting systems.
Epidemiologists from the Africa Centres for Disease Control and Prevention are working alongside local teams to monitor adverse effects and assess immune responses in vaccinated populations. Officials stressed that early detection, combined with isolation and supportive treatment, remains critical for enhancing patient survival chances. Additional vaccine supplies are planned for delivery as distribution extends to secondary health districts.
Kisangani Acts as Central Hub for Regional Ebola Vaccine Distribution
National teams are expanding contact-tracing efforts across both urban and rural areas in the eastern region. Local health centers are supplied with personal protective equipment, diagnostic reagents, and therapeutic materials to enhance readiness. The government has affirmed that comprehensive public health measures will stay active until viral transmission rates decline steadily across all affected provinces.
Authorities urge communities to cooperate fully with mobile vaccination units and follow established health guidelines. Experts believe that increasing immunization among high-risk populations will help stabilize infection rates over the upcoming weeks. Vigilant surveillance at transportation hubs and border crossings will continue to prevent further spread across regions.